{
    "clinical_study": {
        "@rank": "122592", 
        "arm_group": [
            {
                "arm_group_label": "Albumin", 
                "arm_group_type": "Active Comparator", 
                "description": "albumin was administered to reach CVP up to 7mmHg"
            }, 
            {
                "arm_group_label": "6% hydroxyethyl starch 130/0.4", 
                "arm_group_type": "Experimental", 
                "description": "6% hydroxyethyl starch 130/0.4 was administered to reach CVP up to 7mmHg"
            }
        ], 
        "brief_summary": {
            "textblock": "From postoperative patients having undergone pancreaticoduodenectomy;\n\n        1. To compare the hemodynamic parameters from the patient administrated 5% HA and 6%\n           Voluven\n\n        2. To assess the efficacy of the treatment as regards the clinical outcomes and laboratory\n           parameters of the patient\n\n        3. To compare the safety of the 2 intravenous colloids in the patient population"
        }, 
        "brief_title": "Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": "Pancreaticoduodenectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects should be meet inclusion criteria to participated into the study\n\n               1. Age-from 18-75 years adult\n\n               2. In the immediate post-operative period of pancreaticoduodenectomy\n\n               3. Written informed consent and admitted ICU immediate post-operative patient\n\n        Exclusion Criteria:\n\n          -  Any patient meeting one or more of the following exclusion criteria may not be\n             entered into the study.\n\n               1. Refusal to participate in the study\n\n               2. Evidence of pre-operative oliguria (Serum creatinine>1.5mmol/dL)\n\n               3. Known Severe congestive heart failure (NYHAIII,IV)\n\n               4. Known severe respiratory diseases (PaO2/FiO2 <200)\n\n               5. Known coagulopathy (Platelet<100k/mm3, aPTT>70s, PT(INR)>2.5)\n\n               6. Known allergy to hydroxyethyl starch\n\n               7. Known pregnancy or lactation\n\n               8. Has participated in any other clinical trial within 3months\n\n               9. Any contraindication to Voluven\u00ae or albumin according to their package\n                  inserts."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758172", 
            "org_study_id": "2008-1001"
        }, 
        "intervention": [
            {
                "arm_group_label": "6% hydroxyethyl starch 130/0.4", 
                "intervention_name": "6% hydroxyethyl starch 130/0.4", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Albumin", 
                "intervention_name": "Albumin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hetastarch"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pancreaticoduodenectomy", 
            "postoperative patient", 
            "colloid", 
            "albumin", 
            "hetastarch"
        ], 
        "lastchanged_date": "January 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Asan Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Hemodynamic and Clinical Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy", 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Song-cheol Kim, MD., PhD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Mean arterial pressure", 
            "safety_issue": "Yes", 
            "time_frame": "post-op 24hr"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758172"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Song Cheol Kim", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Volume(ml) of colloid", 
            "safety_issue": "No", 
            "time_frame": "post-op 24hrs"
        }, 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}